RecallDepth
Class II Ongoing

Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-410-02

Company
Cipla Usa, Inc.
Recall Initiated
November 14, 2025
Posted
December 17, 2025
Recall Number
D-0224-2026
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
63,504 bottles
Firm Location
Warren, NJ, United States

Reason for Recall

CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.

Distribution

Nationwide in the US

Lot / Code Info

Lot, expiry: Lot 4PB0109, exp 1/31/2026; Lot 5PB0172, exp 1/31/2027

More recalls by Cipla Usa, Inc.

View all recalls by this company →

Other recent Class II Drug recalls